Two female mental health patients drown while chained up in police van
Here is what's new about Apple Watch Series 4
Think twice before starting to take daily aspirin
Ground-breaking research finds daily aspirin dose doesn't lead to longer life
The 4 Announcements From Apple's iPhone Event That Actually Matter
FDA greenlights GW's Epidiolex, the first U.S. drug made from marijuana
26 June 2018, 10:17 | Melissa Porter
Marissa Parsons who has Lennox Gastaut syndrome visits the Grand Canyon with her family in 2016
"This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies", saidFDA Commissioner Scott Gottlieb during a call with reporters about the approval. As well, CBD remains in a legal grey area, making it hard for patients outside of legal states to acquire. This is the approval of one specific CBD medication for a specific use.
Still, Jackson is glad that her family's experience could now provide new treatment options for other childhood seizure sufferers.
There are likely to be drug interactions, she said, but "that's not uncommon for antiepileptic medications", and she noted that this could affect the effectiveness of the medication. The medication has been approved for patients aged two years or older and marks the first time the agency has approved a drug derived from cannabis.
He said the FDA would review legitimate applications for approval but said the agency needed solid scientific studies that demonstrate whether a product actually works and is safe. Carreno says that a leader drug like Epidiolex often paves the way for other less expensive-and untested-CBD products. This drug does not contain THC, which is the part of the marijuana plant that would get someone high.
The medication, which will continue to be manufactured in Britain, will be marketed by Greenwich Biosciences, the US subsidiary of GW Pharmaceuticals.
Patients, parents of children suffering from severe epilepsy, and some researchers have long suspected CBD's potential to treat the devastating seizure disorders.
"This is clearly a breakthrough drug for an very bad disease", John Mendelson, a panel member and senior scientist at the Friends Research Institute, said at a public FDA meeting this spring that was called to discuss the scientific merits of the drug.
Dravet syndrome is a rare genetic condition that causes frequent fever-related seizures, involuntary muscle spasms and a potentially life-threatening state of continuous seizure activity requiring emergency medical care.
Despite increasing acceptance, there is little rigorous research on the benefits and harms of marijuana. We've known for years that cannabidiol is a powerful cannabinoid with legitimate and proven medical properties.
Many companies sell cannabis-based treatments, touting them as cancer cures, pain relievers and anxiety medicines. The company expects this to happen in the next 90 days. European approval is expected in early 2019.
Argentina have last shot at World Cup salvation
Croatia has no pressure in its match against Iceland , which must win its final Group D game in Rostov-on-Don to advance. Oliseh added, "I will love to see Belgium play Nigeria in the knockout stages of the World Cup ".